Haley R. Pugsley, Ph.D., is a Senior Research Scientist for Merck. Haley received her Ph.D. in Analytical Chemistry from the University of Washington working under the direction of Professor Norman J. Dovichi. At the University of Washington she used capillary electrophoresis to study protein fingerprinting of breast cancer tissue and created two reporter cell lines to investigate the expression of RecA in Deinococcus radiodurans.
Dr. Pugsley did her postdoctoral fellowship at Hematologics, Inc. under the direction of Dr. Michael R. Loken where she focused on clinical flow cytometry and its use in diagnosing hematologic malignancies. Dr. Pugsley joined Amnis (now part of Merck) in 2011 developing applications for both the ImageStreamX Mark II and FlowSight imaging flow cytometers. During her time at Merck, Dr. Pugsley has worked on many applications including autophagy, immunological synapse, algae biomass, cell signaling, exosomes and most recently an automated method for leukemia detection using multi-parametric analysis of imaging flow cytometry data.
Amnis is a part of Milipore Sigma. Visit the website.